Jacobs Levy Equity Management Inc. Sells 102,058 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Key Points

• Jacobs Levy Equity Management Inc. reduced its stake in Aveanna Healthcare by 19.1%, owning 431,138 shares valued at approximately $2.34 million after selling 102,058 shares in the first quarter.
• Institutional investors hold 87.96% of Aveanna Healthcare's stock, with notable increases from firms such as Millennium Management and Mackenzie Financial Corp.
• Analyst ratings for Aveanna Healthcare have mixed sentiments, with target prices ranging from $5.00 to $9.50, reflecting a consensus average rating of "Moderate Buy."

Jacobs Levy Equity Management Inc. lessened its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 19.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 431,138 shares of the company's stock after selling 102,058 shares during the quarter. Jacobs Levy Equity Management Inc. owned 0.22% of Aveanna Healthcare worth $2,337,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in AVAH. Raymond James Financial Inc. acquired a new position in shares of Aveanna Healthcare in the 4th quarter worth approximately $155,000. Tower Research Capital LLC TRC raised its stake in shares of Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Aveanna Healthcare by 5.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company's stock worth $246,000 after buying an additional 2,649 shares in the last quarter. Northern Trust Corp raised its stake in shares of Aveanna Healthcare by 11.3% in the 4th quarter. Northern Trust Corp now owns 478,907 shares of the company's stock worth $2,189,000 after buying an additional 48,572 shares in the last quarter. Finally, Algert Global LLC raised its position in shares of Aveanna Healthcare by 33.5% during the fourth quarter. Algert Global LLC now owns 43,095 shares of the company's stock worth $197,000 after purchasing an additional 10,806 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.

Analyst Ratings Changes

AVAH has been the topic of several recent analyst reports. Raymond James Financial raised Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 price target on the stock in a research report on Monday, August 11th. Jefferies Financial Group upgraded Aveanna Healthcare from a "hold" rating to a "buy" rating and lowered their target price for the company from $6.25 to $6.00 in a research note on Monday, July 21st. Wall Street Zen upgraded Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. UBS Group upgraded Aveanna Healthcare from a "sell" rating to a "neutral" rating and upped their price target for the stock from $6.75 to $8.00 in a research note on Tuesday, August 19th. Finally, Barclays raised Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $7.50.

Aveanna Healthcare Price Performance

Shares of AVAH traded down $0.16 during mid-day trading on Tuesday, reaching $8.23. The company had a trading volume of 927,077 shares, compared to its average volume of 1,271,215. The company's 50-day moving average is $6.10 and its 200-day moving average is $5.37. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.67 and a twelve month high of $8.54. The company has a market capitalization of $1.72 billion, a P/E ratio of 102.88 and a beta of 2.04.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.